Overcoming barriers in progressive multiple sclerosis research von Coetzee, Timothy, Zaratin, Paola, Gleason, Trevis L

Volltext

Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis von Fox, Robert J, Coffey, Christopher S, Conwit, Robin, Cudkowicz, Merit E, Gleason, Trevis, Goodman, Andrew, Klawiter, Eric C, Matsuda, Kazuko, McGovern, Michelle, Naismith, Robert T, Ashokkumar, Akshata, Barnes, Janel, Ecklund, Dixie, Klingner, Elizabeth, Koepp, Maxine, Long, Jeffrey D, Natarajan, Sneha, Thornell, Brenda, Yankey, Jon, Bermel, Robert A, Debbins, Josef P, Huang, Xuemei, Jagodnik, Patricia, Lowe, Mark J, Nakamura, Kunio, Narayanan, Sridar, Sakaie, Ken E, Thoomukuntla, Bhaskar, Zhou, Xiaopeng, Krieger, Stephen, Alvarez, Enrique, Apperson, Michelle, Bashir, Khurram, Cohen, Bruce A, Coyle, Patricia K, Delgado, Silvia, Dewitt, L. Dana, Flores, Angela, Giesser, Barbara S, Goldman, Myla D, Jubelt, Burk, Lava, Neil, Lynch, Sharon G, Moses, Harold, Ontaneda, Daniel, Perumal, Jai S, Racke, Michael, Repovic, Pavle, Riley, Claire S, Severson, Christopher, Shinnar, Shlomo, Suski, Valerie, Weinstock-Guttman, Bianca, Yadav, Vijayshree, Zabeti, Aram

Volltext

A Phase II Trial of Ibudilast in Progressive Multiple Sclerosis (CT.004) von Fox, Robert, Ashokkumar, Akshata, Barnes, Janel, Chase, Marianne, Coffey, Christopher, Conwit, Robin, Cudkowicz, Merit, Ecklund, Dixie, Gleason, Trevis, Goodman, Andrew, Klawiter, Eric, Klinger, Elizabeth, Koepp, Maxine, Matsuda, Kazuko, McGovern, Michelle, Naismith, Robert, Yankey, Jon

Volltext

Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis von Fox, Robert J, Coffey, Christopher S, Cudkowicz, Merit E, Gleason, Trevis, Goodman, Andrew, Klawiter, Eric C, Matsuda, Kazuko, McGovern, Michelle, Conwit, Robin, Naismyth, Robert, Ashokkumar, Akshata, Bermel, Robert, Ecklund, Dixie, Koepp, Maxine, Long, Jeffrey, Natarajan, Sneha, Ramachandran, Srividya, Skaramagas, Thomai, Thornell, Brenda, Yankey, Jon, Agius, Mark, Bashir, Khurram, Cohen, Bruce, Coyle, Patricia, Delgado, Silvia, Dewitt, Dana, Flores, Angela, Giesser, Barbara, Goldman, Myla, Jubelt, Burk, Lava, Neil, Lynch, Sharon, Miravalle, Augusto, Moses, Harold, Ontaneda, Daniel, Perumal, Jai, Racke, Michael, Repovic, Pavle, Riley, Claire, Severson, Christopher, Shinnar, Shlomo, Suski, Valerie, Weinstock-Gutman, Bianca, Yadav, Vijayshree, Zabeti, Aram

Volltext

Primary and secondary progressive MS subjects in clinical trials: Are they similar? (P2.059) von Fox, Robert, Ashokkumar, Akshata, Coffey, Christopher, Conwit, Robin, Cudkowicz, Merit, Ecklund, Dixie, Gleason, Trevis, Goodman, Andrew, Klawiter, Eric, Koepp, Maxine, Matsuda, Kazuko, McGovern, Michelle, Naismith, Robert, Natarajan, Sneha, Thornell, Brenda, Yankey, Jon

Volltext

NN 102/SPRINT-MS Phase II Trial of Ibudilast in Progressive MS: Baseline Characteristics (P7.214) von Fox, Robert, Coffey, Christopher, Cudkowicz, Merit, Gleason, Trevis, Goodman, Andrew, Klawiter, Eric, Matsuda, Kazuko, McGovern, Michelle, McNeil, Elizabeth, Naismith, Robert, Yankey, Jon

Volltext